Black Diamond Therapeutics, Inc. (BDTX)

CIK 1701541 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Black Diamond Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 5, 202610-Q0001701541-26-000025
Aug 5, 20268-K0001701541-26-000023
Jul 27, 2026SCHEDULE 13G0002012383-26-002206
Jul 8, 2026SCHEDULE 13G/A0001897612-26-000526
Jun 29, 202640001456849-26-000002
Jun 29, 202640001556064-26-000002
Jun 29, 202640002018966-26-000007
Jun 29, 20268-K0001104659-26-078847
Jun 29, 202640002018686-26-000012
Jun 29, 202640001682019-26-000002
Jun 29, 202640001193125-26-288598
Jun 22, 202640002018686-26-000008
Jun 22, 202640001193125-26-277553
May 21, 20268-K0001104659-26-065254
May 7, 202610-Q0001701541-26-000017
May 7, 20268-K0001701541-26-000015
Apr 29, 2026DEFA14A0001104659-26-051492
Apr 29, 2026DEF 14A0001104659-26-051474
Apr 29, 2026ARS0001104659-26-051509
Mar 20, 202640002018686-26-000002
Mar 20, 202640001193125-26-117938
Mar 16, 20268-K0001701541-26-000008
Mar 16, 202610-K0001701541-26-000009
Mar 16, 2026S-80001104659-26-028461
Feb 17, 2026SCHEDULE 13G/A0000902664-26-001085